1.Genomic and Molecular Characterization of Brain Tumors in Asian and Non-Asian Patients of Los Angeles: A Single Institution Analysis.
Courtney DUONG ; Thien NGUYEN ; John P SHEPPARD ; Vera ONG ; Lawrance K CHUNG ; Daniel T NAGASAWA ; Isaac YANG
Brain Tumor Research and Treatment 2017;5(2):64-69
BACKGROUND: Worldwide, approximately 2% of new cancers are of the brain. Five-year survival rates among brain cancer patients have been reported as a little over a third. Differences in clinical outcomes between brain tumor patients of different races remain poorly understood. METHODS: A retrospective chart review was performed on brain tumor resection patients≥18 years old. Demographics, treatment variables, and survival outcomes were collected. Primary outcomes were length of stay, recurrence rate, progression-free survival (PFS), and overall survival (OS). RESULTS: A total of 452 patients were included in analysis. Females and males had nearly a 1:1 ratio (n=242 and n=220, respectively). Mean age was 54.8 years (SD: 14.5 range: 18–90). Females composed 69% (n=48) of Asian patients; males constituted 31% (n=22). Mean age of the Asian patients was 55.9 years (SD: 14.6 range: 26–89). Asian-only cohort tumor pathologies included glioblastoma (GBM) (n=14), high-grade glioma (n=7), low-grade glioma (n=4), meningioma (n=38), and metastases (n=7). Of the 185 meningioma patients, non-Asian patients comprised 79% of the group (n=146). Of the 65 GBM patients in total, non-Asian patients made up 89% of the GBM cohort (n=58). There were no statistically significant differences between these groups of both cohorts in recurrence (p=0.1580 and p=0.6294, respectively), PFS (p=0.9662 and p=0.4048, respectively), or OS (p=0.3711 and p=0.8183, respectively). CONCLUSION: Studies evaluating the survival between patients of different racial backgrounds against several tumor varieties are rare. Patients of certain racial backgrounds may need additional consideration when being attended to despite the same mutational composition as their counterparts. Repeated studies using national databases may yield more conclusive results.
Asian Continental Ancestry Group*
;
Biomarkers
;
Brain Neoplasms*
;
Brain*
;
Cohort Studies
;
Continental Population Groups
;
Demography
;
Disease-Free Survival
;
Female
;
Glioblastoma
;
Glioma
;
Humans
;
Length of Stay
;
Male
;
Meningioma
;
Neoplasm Metastasis
;
Pathology
;
Recurrence
;
Retrospective Studies
;
Survival Rate
2.Risk of Brain Tumor Induction from Pediatric Head CT Procedures: A Systematic Literature Review.
John P SHEPPARD ; Thien NGUYEN ; Yasmine ALKHALID ; Joel S BECKETT ; Noriko SALAMON ; Isaac YANG
Brain Tumor Research and Treatment 2018;6(1):1-7
Head computed tomography (CT) is instrumental for managing patients of all ages. However, its low dose radiation may pose a low but non-zero risk of tumor induction in pediatric patients. Here, we present a systematic literature review on the estimated incidence of brain tumor induction from head CT exams performed on children and adolescents. MEDLINE was searched using an electronic protocol and bibliographic searches to identify articles related to CT, cancer, and epidemiology or risk assessment. Sixteen studies that predicted or measured head CT-related neoplasm incidence or mortality were identified and reviewed. Epidemiological studies consistently cited increased tumor incidence in pediatric patients (ages 0–18) exposed to head CTs. Excess relative risk of new brain tumor averaged 1.29 (95% confidence interval, 0.66–1.93) for pediatric patients exposed to one or more head CTs. Tumor incidence increased with number of pediatric head CTs in a dose-dependent manner, with measurable excess incidence even after a single scan. Converging evidence from epidemiological studies supported a small excess risk of brain tumor incidence after even a single CT exam in pediatric patients. However, refined epidemiological methods are needed to control for confounding variables that may contribute to reverse causation, such as patients with pre-existing cancer or cancer susceptibility. CT remains an invaluable technology that should be utilized so long as there is clinical indication for the study and the radiation dose is as small as reasonably achievable.
Adolescent
;
Brain Neoplasms*
;
Brain*
;
Child
;
Confounding Factors (Epidemiology)
;
Epidemiologic Methods
;
Epidemiologic Studies
;
Epidemiology
;
Head*
;
Humans
;
Incidence
;
Mortality
;
Patient Safety
;
Pediatrics
;
Radiometry
;
Risk Assessment
;
Tomography, X-Ray Computed
3.Racial Differences in Hospital Stays among Patients Undergoing Craniotomy for Tumour Resection at a Single Academic Hospital
John P SHEPPARD ; Carlito LAGMAN ; Prasanth ROMIYO ; Thien NGUYEN ; Daniel AZZAM ; Yasmine ALKHALID ; Courtney DUONG ; Isaac YANG
Brain Tumor Research and Treatment 2019;7(2):122-131
BACKGROUND: Racial differences in American patients undergoing brain tumour surgery remain poorly characterized within urban medical centres. Our objective was to assess racial differences in operative brain tumour patients at a single academic hospital in Los Angeles, California. METHODS: We reviewed medical records of adult patients undergoing craniotomy for tumour resection from March 2013 to January 2017 at UCLA Medical Centre. Patients were categorized as Asian, Hispanic, Black, or White. Racial cohorts were matched on demographic variables for comparisons. Our primary outcome was post-operative length of stay (LOS). Secondary outcomes included hospital mortality and discharge disposition. RESULTS: In this study, 462 patients identified as Asian (15.1%), Hispanic (8.7%), Black (3.9%), or White (72.3%). After cohort matching, non-White patients had elevated risk of prolonged LOS [odds ratio (OR)=2.62 (1.44, 4.76)]. No differences were observed in hospital mortality or non-routine discharge. Longer LOS was positively correlated with non-routine discharge [r(pb) (458)=0.41, p<0.001]. Black patients with government insurance had average LOS 2.84 days shorter than Black patients with private insurance (p=0.04). Among Hispanics, government insurance was associated with non-routine discharge [OR=4.93 (1.03, 24.00)]. CONCLUSION: Racial differences manifested as extended LOS for non-White patients, with comparable rates of hospital mortality and non-routine discharge across races. Prolonged LOS loosely reflected complicated clinical course with greater risk of adverse discharge disposition. Private insurance coverage predicted markedly lower risk of non-routine discharge for Hispanic patients, and LOS of three additional days among Black patients. Further research is needed to elucidate the basis of these differences.
Adult
;
Asian Continental Ancestry Group
;
Brain
;
Brain Neoplasms
;
California
;
Cohort Studies
;
Continental Population Groups
;
Craniotomy
;
Hispanic Americans
;
Hospital Mortality
;
Humans
;
Insurance
;
Insurance Coverage
;
Length of Stay
;
Medical Records
;
Socioeconomic Factors